Central line-associated bloodstream infection (CLABSI) occurrence is arguably 100% preventable, yet central venous access device (CVAD) related infections have a 12-25% mortality rate in the ICU setting1. One to 2 of every 8 patients who develop CLABSI don’t survive. In the webinar, 18 Months of Sticking to it: Dedicated team site care using gum mastic…
Vascular Access Dressing Adherence and Hospital-acquired Infections Central venous access device (CVAD) related infections have a 12‐25% mortality in ICU populations. [1] Due to dressing disruption, central line‐associated bloodstream infection (CLABSI) may occur. The US Centers for Disease Control and Prevention (CDC) and the Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing…
In October of 2018, the Association for Professionals in Infection Control and Epidemiology (APIC) working together with the US Centers for Disease Control and Prevention (CDC) launched a series of Quick Observation Tools (QUOTs) to assist healthcare facilities in their infection prevention initiatives.[1] The tools, available for free download here, enable rapid assessment and remediation…
Vascular Access Devices and Dressing Adherence The US Centers for Disease Control and Prevention (CDC) and The Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing integrity is a critical factor for the prevention of hospital‐ acquired infection. [1,2] In fact, dressing disruption is a major risk factor for central line‐associated bloodstream infections…
While catheters provide numerous benefits to their users, there can be a health burden associated with their use, as they may promote catheter-related bloodstream infection (CRBSI*) and medical adhesive-related skin injuries (MARSIs). A publication reviewing the qualitative and quantitative evidence supporting the use of Detachol® Liquid Adhesive for the reduction of CRBSI and MARSI can…
Of the 200 million people worldwide who have been diagnosed with diabetes, millions receive their diabetes care through insulin pump therapy and use continuous glucose monitors (CGMs) and insulin pumps.[1] This may result in improved diabetes care and greater control over users’ blood glucose levels. “My overall health is better. Insulin delivery is better, so…
Vascular Access Devices (VADs) are more prevalent than ever, with some reports estimating that at any point in time there may be 5 million patients living with a VAD.[1] These patients may either be in the hospital receiving care or at home receiving longterm care, and while VADs offer flexibility to patients, VADs still have…
The public health burden associated with catheter‐related bloodstream infection (CRBSI*) is substantial. A publication reviewing the qualitative and quantitative evidence supporting the use of Mastisol® Liquid Adhesive for the reduction of CRBSI can be downloaded here. In this blog, we’ll review the important findings detailed in this publication. CRBSI vs CLABSI These two…
The US Centers for Disease Control and Prevention (CDC) and The Infusion Nurses Society (INS) agree that vascular access device (VAD) dressing integrity is a critical factor for the prevention of hospital acquired infection. Michelle DeVries, BS, MPH, CIC, VA-BC, Senior Infection Control Officer at Methodist Hospitals, Indiana, reviews current practice guidelines, the emerging literature, and her…
The last blog began a 3-part series focusing on catheter-related bloodstream infections (CRBSIs). We saw that as vascular catheter use has increased, bloodstream infections have become a costly complication of health care. We also reviewed how preventing dressing disruption with Mastisol Liquid Adhesive® reduces the likelihood of dressing displacement and minimizes the risk of infection.…